{
    "clinical_study": {
        "@rank": "124247", 
        "arm_group": {
            "arm_group_label": "Ultraviolet-A and riboflavin", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application\n      (also often referred to as corneal collagen crosslinking) as a method to enhance treatment\n      of infectious keratitis."
        }, 
        "brief_title": "Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infectious Keratitis", 
        "condition_browse": {
            "mesh_term": [
                "Communicable Diseases", 
                "Infection", 
                "Keratitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subjects must be 18 years of age or older.\n\n          2. Ability to provide written informed consent.\n\n          3. Likely to complete all study visits.\n\n          4. Subjects must have one eye that with a diagnosis of infectious keratitis.\n\n        Exclusion Criteria:\n\n          1. A corneal perforation.\n\n          2. Descemetocele.\n\n          3. Pregnancy or breastfeeding.\n\n          4. Active Herpes corneal disease.\n\n          5. Patient is unwilling or unable to comply with a medication regimen and follow up\n             appointments."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01739673", 
            "org_study_id": "iCXL"
        }, 
        "intervention": {
            "arm_group_label": "Ultraviolet-A and riboflavin", 
            "intervention_name": "Ultraviolet-A and riboflavin", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Riboflavin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Infectious Keratitis", 
        "lastchanged_date": "November 30, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "Schwartz Laser Eye Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Hills", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Davidorf Eye Group"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Littleton", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "Corneal Consultants of Colorado, PC"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Center for Excellence in Eye Care"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "Minnesota Eye Consultants"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Ophthalmology Associates"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis", 
        "overall_contact": {
            "email": "kristin@lexitaspharma.com", 
            "last_name": "Kristin Williams"
        }, 
        "overall_official": {
            "affiliation": "Center For Excellence In Eye Care", 
            "last_name": "William Trattler, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Resolution of Signs and Symptoms of Infectious Keratitis", 
            "safety_issue": "No", 
            "time_frame": "Subjects will be followed until resolution of signs and symptoms, an expected average of 8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01739673"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cxlusa", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cxlusa", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}